ITGAM and neoplasm: Interestingly, penetration of CD11b+ cells to the tumor core was not found to be a negative predictor of tumor response to PD-1 blockade 21, potentially due to the diversity and polarization of CD11b+ cells, which can serve as both anti-tumor and pro-tumor roles.